TechConnect World 2018
Co-Located with Nanotech 2018 SBIR/STTR Spring Defense TechConnect
Nanotech 2018
 

Cancer Nanotechnology

Cancer Nanotechnology

Sponsored by:
NanoMedicines Alliance

Symposium Co-Chairs

Mansoor M.  AmijiMansoor M. Amiji
Distinguished Professor & Chair, Dept. of Pharmaceutical Sciences, Co-Director, Nanomedicine Education & Research Consortium
Northeastern University

Anil  PatriAnil Patri
Director, NCTR/ORA NanoCore, National Center for Toxicological Research
U.S. Food and Drug Administration

Key Speakers

Sanyogitta PuriNanomedicine design, development and translation into clinical trials in Oncology- An industrial perspective
Sanyogitta Puri
Associate Principle Scientist, AstraZeneca, United Kingdom

Mark E. DavisNanoparticle Therapeutics: From Concept to Clinic
Mark E. Davis
Warren and Katharine Schlinger Professor of Chemical Engineering, California Institute of Technology

Frank  SzokaInnovation that Enables the Encapsulation of Sparingly Soluble Drugs for Delivery in Liposomes
Frank Szoka
Co-Founder, Chairman of the Board, ZoneOne Pharma

Puneet  TyagiEvaluation of Pyrrolobenzodiazepine loaded Nanoparticles : A potential targeted drug delivery approach
Puneet Tyagi
Scientist II , MedImmune

Symposium Sessions

Monday May 14

10:30Cancer Nanotechnology
1:30Cancer Therapy & Diagnostics Delivery

Tuesday May 15

4:00Diagnostics & Bioimaging: Posters
4:00Cancer Nanotechnology: Poster

Symposium Program

Monday May 14

10:30Cancer Nanotechnology252 A
Session chair: Anil Patri, U.S. Food & Drug Administration, US
10:30Nanoparticle Therapeutics: From Concept to Clinic (invited presentation)
M.E. Davis, California Institute of Technology, US
10:55Nanomedicine design, development and translation into clinical trials in Oncology- An industrial perspective (invited presentation)
S. Puri, AstraZeneca, UK
11:20Cancer Nanotechnology (invited presentation)
A. Patri, U.S. Food & Drug Administration, US
11:45Overcoming Challenges in Manufacturing Scale-Up of Plasmonic Gold Nanorods: Bringing Photothermal Therapy to the Clinic.
L. Pagliaro, Siva Therapeutics Inc, US
12:05Numerical investigation of Electric field, Ion Transport and pH damage during Electrochemical Treatment of Tumors: Effects of physicochemical reactions and chlorine bleaching
A. Mokthare, S.K. Reddy, E.P. Furlani, University at Buffalo, US
1:30Cancer Therapy & Diagnostics Delivery252 A
Session chair: Anil Patri, U.S. Food and Drug Administration, US; Steve Zullo, NIBIB/NIH, US
1:30Innovation that Enables the Encapsulation of Sparingly Soluble Drugs for Delivery in Liposomes (invited presentation)
F.C. Szoka, C.O. Noble, M.E. Hayes, University of California, San Francisco, US
1:55MRI-Guided Focused Ultrasound: A Transformative, State-of-the-Art Technology for 21st Century Medicine (invited presentation)
P. Anastasiadis, University of Maryland School of Medicine, US
2:20Evaluation of Pyrrolobenzodiazepine loaded Nanoparticles : A potential targeted drug delivery approach (invited presentation)
P. Tyagi, MedImmune, US
2:45Silver nanoparticles for use in precision medicine-based cancer therapies
J. Swanner, C.D. Fahrenholtz, P.-A. Vidi, K.L. Cook, M. McMahon, I. Tenvooren, B.W. Bernish, J.J. Sears, G.L. Donati, R.N. Singh, Wake Forest School of Medicine, US
3:05Functional Polylactide-based Systems for Delivery of Cancer Therapeutics
C. Cheng, H. Sun, Y. Yu, C-K Chen, J. Zou, University at Buffalo, the State University of New York, US
3:25In vitro and In vivo evaluation of 2-amino-7(8)-fluorophenazine N5,N10-dioxide within polymeric micelles as theranostic agents
N. Lecot, Centro de Investigaciones Nucleares. Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay., UY
3:45Paving a Path for the Clinic – Preclinical Characterization of Nanomedicine (invited presentation)
M. Scully, Frederick National Laboratory for Cancer Research, US

Tuesday May 15

4:00Diagnostics & Bioimaging: PostersExpo Hall
Design and synthesis of novel and privileged small Molecules for prevention and treatment of MRSA and polymicrobial infections
T.H. Al-Tel, F.I. Al-Marzooq, S. Vunnam, University of Sharjah, AE
A Cell-Sensory Bioscaffold of Biocompatible Titanate Nanofiber
H. Alismail, University of Arkansas, US
Single Step Copper Loading of Nanoparticles for PET-Imaging
R.K. Prud'homme, Princeton University, US
Preparation and characterization of nanofibers for the wound healing
S-K. Lee, S.K. Lim and S-H. Hwang, DGIST, KR
Hyaluronic acid-cyclodextrin crosslinked nanofibers for medical applications
M. Seon-Lutz, A. Hebraud, A-C. Couffin, S. Vignoud, G. Schlatter, CEA-Leti, FR
Rapid and scalable formulation and radiolabeling of phthalocyanine-based nanoparticles as a platform for targeted PET
R.K. Prud'homme, L.Z. Wang, H.D. Lu, B.K. Wilson, S.A. McManus, P.K. Padakanti, A. Alavi, R.H. Mach, Princeton University, US
Profiling and Maximizing Critical Thinking Readiness in the Workforce
F.C. Feucht, Thinking Habitats, US
Fluorescence Lifetime Trajectory of the Mouse Pre-Implantation Embryopredicts its Viability
N. Ma, N.R. de Mochel, T.Y. Yoo, P.D.A. Pham, K. Cho, M.A. Digman, University of California, Irvine, US
4:00Cancer Nanotechnology: PosterExpo Hall
Cancer Nanotherapy Promted by a Molecular Capsule that Targets the Cell Nucleus
Y. Fang, H-C Zhou, Texas A&M University, US
Graphenoid plates in glioma therapy.
M. Grodzik, J. Szczepaniak, B. Strojny, J. Jaworski, M. Wierzbicki, J. Jagiello, E. Soltan, T. Mandat, Warsaw University of Life Sciences (WULS), PL
Layer-by-Layer Nanoparticles for the Detection and Treatment of Ovarian Cancer
N. Boehnke, S. Correa, L. Hao, W. Wang, S. N. Bhatia, P. T. Hammond, Massachusetts Institute of Technology, US
Cancer Nanotherapy Promted by a Molecular Capsule that Targets the Cell Nucleus
Yu Fang, Hong-Cai Zhou, Texas A&M University, US
Microwave Resonater Treatment by AAO Nano Filter and Nanoflowers Filter for Killing Cancer Cell in Blood Dialysis System
N-Y. Kim and E-S. Kim, Kwangwoon University, KR

This symposium will highlight the ways in which nanotechnology can address challenges of cancer detection, diagnosis and therapy. Distinguished speakers will summarize the current state of the art and share the excitement surrounding approaches and materials that will have a revolutionary impact on cancer treatment in the future. Contributions are also solicited in the following topics:

 
2018 Sponsors & Partners
2018 Sponsors & Partners